{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:15:41Z","timestamp":1760645741375},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T00:00:00Z","timestamp":1269302400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Epidemiological studies show wide variability in the occurrence of cannabis smoking and related disorders across countries. This study aims to estimate cross-national variation in cannabis users' experience of clinically significant cannabis-related problems in three countries of the Americas, with a focus on cannabis users who may have tried alcohol or tobacco, but who have not used cocaine, heroin, LSD, or other internationally regulated drugs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Data are from the World Mental Health Surveys Initiative and the National Latino and Asian American Study, with probability samples in Mexico (n = 4426), Colombia (n = 5,782) and the United States (USA; n = 8,228). The samples included 212 'cannabis only' users in Mexico, 260 in Colombia and 1,724 in the USA. Conditional GLM with GEE and 'exact' methods were used to estimate variation in the occurrence of clinically significant problems in cannabis only (CO) users across these surveyed populations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The experience of cannabis-related problems was quite infrequent among CO users in these countries, with weighted frequencies ranging from 1% to 5% across survey populations, and with no appreciable cross-national variation in general. CO users in Colombia proved to be an exception. As compared to CO users in the USA, the Colombia smokers were more likely to have experienced cannabis-associated 'social problems' (odds ratio, OR = 3.0; 95% CI = 1.4, 6.3; p = 0.004) and 'legal problems' (OR = 9.7; 95% CI = 2.7, 35.2; p = 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study's most remarkable finding may be the similarity in occurrence of cannabis-related problems in this cross-national comparison within the Americas. Wide cross-national variations in estimated population-level cumulative incidence of cannabis use disorders may be traced to large differences in cannabis smoking prevalence, rather than qualitative differences in cannabis experiences. More research is needed to identify conditions that might make cannabis-related social and legal problems more frequent in Colombia than in the USA.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2458-10-152","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T19:15:01Z","timestamp":1269371701000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cross-national differences in clinically significant cannabis problems: epidemiologic evidence from 'cannabis-only' smokers in the United States, Mexico, and Colombia"],"prefix":"10.1186","volume":"10","author":[{"given":"Fabian","family":"Fiestas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"Radovanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia S","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E","family":"Medina-Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Posada-Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,23]]},"reference":[{"issue":"21","key":"2063_CR1","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1001\/jama.291.21.2581","volume":"291","author":"K Demyttenaere","year":"2004","unstructured":"Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC, Bernert S, de Girolamo G, Morosini P, et al: Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. Jama. 2004, 291 (21): 2581-2590. 10.1001\/jama.291.21.2581.","journal-title":"Jama"},{"key":"2063_CR2","volume-title":"Global Illicit Drug Trends 2003","author":"UN","year":"2003","unstructured":"UN: Global Illicit Drug Trends 2003. 2003, New York: United Nations"},{"issue":"3-4","key":"2063_CR3","first-page":"256","volume":"36","author":"M Kramer","year":"1983","unstructured":"Kramer M, Anthony J: Review of differences in mental health indicators used in national publications: recommendations for their standardization. World Health Stat Q. 1983, 36 (3-4): 256-338.","journal-title":"World Health Stat Q"},{"issue":"3","key":"2063_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0376-8716(02)00224-7","volume":"68","author":"WA Vega","year":"2002","unstructured":"Vega WA, Aguilar-Gaxiola S, Andrade L, Bijl R, Borges G, Caraveo-Anduaga JJ, DeWit DJ, Heeringa SG, Kessler RC, Kolody B, et al: Prevalence and age of onset for drug use in seven international sites: results from the international consortium of psychiatric epidemiology. Drug Alcohol Depend. 2002, 68 (3): 285-297. 10.1016\/S0376-8716(02)00224-7.","journal-title":"Drug Alcohol Depend"},{"issue":"17","key":"2063_CR5","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.291.17.2114","volume":"291","author":"WM Compton","year":"2004","unstructured":"Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS: Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. Jama. 2004, 291 (17): 2114-2121. 10.1001\/jama.291.17.2114.","journal-title":"Jama"},{"issue":"1","key":"2063_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.drugalcdep.2007.02.024","volume":"90","author":"LT Midanik","year":"2007","unstructured":"Midanik LT, Tam TW, Weisner C: Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey. Drug Alcohol Depend. 2007, 90 (1): 72-80. 10.1016\/j.drugalcdep.2007.02.024.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2063_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/mpr.168","volume":"13","author":"RC Kessler","year":"2004","unstructured":"Kessler RC, Ustun TB: The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 2004, 13 (2): 93-121. 10.1002\/mpr.168.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"1","key":"2063_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1360-0443.2003.00237.x","volume":"98","author":"CY Chen","year":"2003","unstructured":"Chen CY, Anthony JC: Possible age-associated bias in reporting of clinical features of drug dependence: epidemiological evidence on adolescent-onset marijuana use. Addiction. 2003, 98 (1): 71-82. 10.1046\/j.1360-0443.2003.00237.x.","journal-title":"Addiction"},{"issue":"2","key":"2063_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1001\/archpsyc.59.2.115","volume":"59","author":"WE Narrow","year":"2002","unstructured":"Narrow WE, Rae DS, Robins LN, Regier DA: Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry. 2002, 59 (2): 115-123. 10.1001\/archpsyc.59.2.115.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"2063_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mpr.220","volume":"16","author":"L Degenhardt","year":"2007","unstructured":"Degenhardt L, Bohnert KM, Anthony JC: Case ascertainment of alcohol dependence in general population surveys: 'gated' versus 'ungated' approaches. Int J Methods Psychiatr Res. 2007, 16 (3): 111-123. 10.1002\/mpr.220.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"3","key":"2063_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.drugalcdep.2007.09.024","volume":"93","author":"L Degenhardt","year":"2008","unstructured":"Degenhardt L, Bohnert KM, Anthony JC: Assessment of cocaine and other drug dependence in the general population: \"gated\" versus \"ungated\" approaches. Drug Alcohol Depend. 2008, 93 (3): 227-232. 10.1016\/j.drugalcdep.2007.09.024.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2063_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/mpr.206","volume":"16","author":"L Degenhardt","year":"2007","unstructured":"Degenhardt L, Cheng H, Anthony JC: Assessing cannabis dependence in community surveys: methodological issues. Int J Methods Psychiatr Res. 2007, 16 (2): 43-51. 10.1002\/mpr.206.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"2","key":"2063_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/mpr.169","volume":"13","author":"RC Kessler","year":"2004","unstructured":"Kessler RC, Abelson J, Demler O, Escobar JI, Gibbon M, Guyer ME, Howes MJ, Jin R, Vega WA, Walters EE, et al: Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI). Int J Methods Psychiatr Res. 2004, 13 (2): 122-139. 10.1002\/mpr.169.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"7","key":"2063_CR14","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1371\/journal.pmed.0050141","volume":"5","author":"L Degenhardt","year":"2008","unstructured":"Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, Bruffaerts R, de Girolamo G, Gureje O, Huang Y, et al: Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008, 5 (7): e141-10.1371\/journal.pmed.0050141.","journal-title":"PLoS Med"},{"issue":"2","key":"2063_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/mpr.167","volume":"13","author":"RC Kessler","year":"2004","unstructured":"Kessler RC, Berglund P, Chiu WT, Demler O, Heeringa S, Hiripi E, Jin R, Pennell BE, Walters EE, Zaslavsky A, et al: The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res. 2004, 13 (2): 69-92. 10.1002\/mpr.167.","journal-title":"Int J Methods Psychiatr Res"},{"key":"2063_CR16","volume-title":"Applied Longitudinal Analysis","author":"GM Fitzmaurice","year":"2004","unstructured":"Fitzmaurice GM, Laird NM, Ware JH: Applied Longitudinal Analysis. 2004, New Jersey: John Wiley & Sons, Inc"},{"issue":"19","key":"2063_CR17","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1002\/sim.4780141908","volume":"14","author":"CR Mehta","year":"1995","unstructured":"Mehta CR, Patel NR: Exact logistic regression: theory and examples. Stat Med. 1995, 14 (19): 2143-2160. 10.1002\/sim.4780141908.","journal-title":"Stat Med"},{"issue":"3","key":"2063_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0899-3289(99)00007-3","volume":"10","author":"RL Collins","year":"1998","unstructured":"Collins RL, Ellickson PL, Bell RM: Simultaneous polydrug use among teens: prevalence and predictors. J Subst Abuse. 1998, 10 (3): 233-253. 10.1016\/S0899-3289(99)00007-3.","journal-title":"J Subst Abuse"},{"key":"2063_CR19","volume-title":"Stata statistical software: Release 10.0","author":"StataCorp","year":"2007","unstructured":"StataCorp: Stata statistical software: Release 10.0. 2007, College Station, TX: Stata Corporation"},{"key":"2063_CR20","volume-title":"LogXact 8","author":"Cytel","year":"2007","unstructured":"Cytel: LogXact 8. 2007, Cambridge, MA: Cytel Inc"},{"issue":"3","key":"2063_CR21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","volume":"187","author":"RR Griffiths","year":"2006","unstructured":"Griffiths RR, Richards WA, McCann U, Jesse R: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl). 2006, 187 (3): 268-283. 10.1007\/s00213-006-0457-5.","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"2063_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1037\/1064-1297.5.4.353","volume":"5","author":"M Earleywine","year":"1997","unstructured":"Earleywine M, Newcomb MD: Concurrent versus simultaneous polydrug use: prevalence, correlates, discriminant validity, and prospective effects on health outcomes. Exp Clin Psychopharmacol. 1997, 5 (4): 353-364. 10.1037\/1064-1297.5.4.353.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1-3","key":"2063_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.drugalcdep.2009.01.007","volume":"102","author":"SE McCabe","year":"2009","unstructured":"McCabe SE, Boyd CJ, Teter CJ: Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend. 2009, 102 (1-3): 63-70. 10.1016\/j.drugalcdep.2009.01.007.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"2063_CR24","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2105\/AJPH.81.11.1423","volume":"81","author":"AL Klatsky","year":"1991","unstructured":"Klatsky AL, Armstrong MA: Cardiovascular risk factors among Asian Americans living in northern California. Am J Public Health. 1991, 81 (11): 1423-1428. 10.2105\/AJPH.81.11.1423.","journal-title":"Am J Public Health"},{"issue":"Suppl 2","key":"2063_CR25","first-page":"62","volume":"111","author":"AL Klatsky","year":"1996","unstructured":"Klatsky AL, Tekawa IS, Armstrong MA: Cardiovascular risk factors among Asian Americans. Public Health Rep. 1996, 111 (Suppl 2): 62-64.","journal-title":"Public Health Rep"},{"issue":"22","key":"2063_CR26","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/jnci\/85.22.1819","volume":"85","author":"RG Ziegler","year":"1993","unstructured":"Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, et al: Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993, 85 (22): 1819-1827. 10.1093\/jnci\/85.22.1819.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"2063_CR27","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/jnci\/87.9.652","volume":"87","author":"AS Whittemore","year":"1995","unstructured":"Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW, et al: Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst. 1995, 87 (9): 652-661. 10.1093\/jnci\/87.9.652.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2063_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1360-0443.2008.02491.x","volume":"104","author":"G Borges","year":"2009","unstructured":"Borges G, Medina-Mora ME, Orozco R, Fleiz C, Cherpitel C, Breslau J: The Mexican migration to the United States and substance use in northern Mexico. Addiction. 2009, 104 (4): 603-611. 10.1111\/j.1360-0443.2008.02491.x.","journal-title":"Addiction"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-10-152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-10-152\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-10-152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-10-152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T06:35:05Z","timestamp":1630478105000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-10-152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,23]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2063"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-10-152","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,23]]},"assertion":[{"value":"21 September 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"152"}}